🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was planned to determine the effects of upper extremity function...
Status
Completed
Location
Atılım University
Start Date
2018-04-01
Trial ID
NCT04099953
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
The purpose of this study was to investigate the effects of a high-intensit...
Status
Completed
Location
Tunisia
Start Date
2025-12-01
Trial ID
NCT07719296
Treatments Being Tested
The aim of the project is to elucidate the impact of diverse sex hormone pr...
Status
Recruiting
Location
Aarhus University, Department for Public Health
Start Date
2025-08-05
Trial ID
NCT07115849
Treatments Being Tested
The purpose of this clinical trial is to evaluate the efficacy and safety o...
Status
Active Not Recruiting
Location
Bionos Biotech Clínica
Start Date
2025-10-13
Trial ID
NCT07111299
Treatments Being Tested
Asthma is a chronic inflammatory bronchial disorder with three distinct com...
Status
Completed
Location
Charité Research Organisation GmbH
Start Date
2012-12
Trial ID
NCT01743768
The goal of this clinical trial is to evaluate the safety, tolerability and...
Status
Recruiting
Location
Universitaetsklinikum Heidelberg AöR
Start Date
2023-08-09
Trial ID
NCT05958121
A Phase 1, randomized, single-blind, placebo-controlled, single dose, dose-...
Status
Completed
Location
TASMC
Start Date
2017-01-22
Trial ID
NCT02919800
Treatments Being Tested
This is a first-in-human, multicenter, Phase 1/2, open-label study designed...
Status
Recruiting
Location
University of California, Davis Comprehensive Cancer Center
Start Date
2023-05-11
Trial ID
NCT05684965
Treatments Being Tested
GSK2879552 is a potent, selective, mechanism-based inactivator of Lysine Sp...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-02-04
Trial ID
NCT02034123
Treatments Being Tested